ArunA Bio competitorsClear all

ArunA Bio's top competitors include Codiak Biosciences, Quentis Therapeutics, TCR CURE Biopharma and Sitryx.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
ArunA Bio
ArunA Bio
ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules.
Codiak Biosciences
Codiak Biosciences
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
Quentis Therapeutics
Quentis Therapeutics
Quentis Therapeutics develops immunotherapies targeting the endoplasmic reticulum stress response to awaken the immune system’s ability to fight cancer.
TCR CURE Biopharma
TCR CURE Biopharma
TCR CURE Biopharma is a company that develops cancer immunotherapies.
Sitryx
Sitryx
Sitryx is a biopharmaceutical company focused on regulating cell metabolism.
Founding Date
Founding Date
2003
Founding Date
2015
Founding Date
2016
Founding Date
2017
Founding Date
2018
Type
Type
Private
Type
Public
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Athens, US HQ
Athens, US
Locations
Cambridge, US HQ
Locations
New York, US HQ
Locations
Los Angeles, US HQ
Guangzhou Shi, CN
Durham, US
Locations
Oxford, GB HQ
London, GB
Employees
Employees
274% increase
Employees
101
Employees
640% decrease
Employees
28
Employees
31
Twitter followers
Twitter followers
222
Twitter followers
180
Twitter followers
183
Twitter followers
N/A
Twitter followers
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
4.2
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3.7

Funding

Latest funding round
Latest funding round
$ 4.5m (almost 2 years ago)
Latest funding round
N/A
Latest funding round
$ 48m (over 3 years ago)
Latest funding round
N/A
Latest funding round
$ 30m (almost 3 years ago)
Total funding raised
Total funding raised
$ 26.9m
Total funding raised
$ 168.5m
Total funding raised
$ 48m
Total funding raised
N/A
Total funding raised
$ 30m
For sources of this data, please see the company profile

View company profiles

Codiak Biosciences
HQ
Cambridge, US
Employees
101

Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.

View company
Quentis Therapeutics
HQ
New York, US
Employees
6↓ 40% decrease

Quentis Therapeutics develops immunotherapies targeting the endoplasmic reticulum stress response to awaken the immune system’s ability to fight cancer.

View company
TCR CURE Biopharma
HQ
Los Angeles, US
Employees
28

TCR CURE Biopharma is a company that develops cancer immunotherapies.

View company
Sitryx
HQ
Oxford, GB
Employees
31

Sitryx is a biopharmaceutical company focused on regulating cell metabolism.

View company